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Whole-exome sequencing in the 
Isolated populations of Cilento from 
south Italy
t. Nutile 1, D. Ruggiero 1,2, A. F. Herzig  3,4, A. tirozzi2, s. Nappo5, R. sorice1, F. Marangio1, 
C. Bellenguez  6,7,8, A. L. Leutenegger  3,4 & M. Ciullo  1,2
the present study describes the genetic architecture of the isolated populations of Cilento, through the 
analysis of exome sequence data of 245 representative individuals of these populations. By annotating 
the exome variants and cataloguing them according to their frequency and functional effects, we 
identified 347,684 variants, 67.4% of which are rare and low frequency variants, and 1% of them 
(corresponding to 319 variants per person) are classified as high functional impact variants; also, 39,946 
(11.5% of the total) are novel variants, for which we determined a significant enrichment for deleterious 
effects. By comparing the allele frequencies in Cilento with those from the Tuscan population from the 
1000 Genomes Project Phase 3, we highlighted an increase in allele frequency in Cilento especially for 
variants which map to genes involved in extracellular matrix formation and organization. Furthermore, 
among the variants showing increased frequency we identified several known rare disease-causing 
variants. By different population genetics analyses, we corroborated the status of the Cilento 
populations as genetic isolates. Finally, we showed that exome data of Cilento represents a useful local 
reference panel capable of improving the accuracy of genetic imputation, thus adding power to genetic 
studies of human traits in these populations.
Genomic studies are playing a crucial role in enlarging knowledge of genetic variation between and within pop-
ulations1 and in identifying the genetic bases of complex traits/diseases. In the last few years, a huge amount 
of genetic data have been collected by whole-exome sequencing (WES) and whole-genome sequencing (WGS) 
studies2–10, performed on different general and isolated populations worldwide, including isolates from Northern 
Italy11. These studies revealed an enrichment for rare and low frequency variants, and identified variants private to 
each examined population. However, none of these studies has included populations from Southern Italy, leading 
to an underrepresentation of their genetic diversity in the genomic data collected to date. To try to fill this gap, 
we have performed a whole-exome sequencing study on individuals from the populations of three small villages 
(Campora, Gioi, and Cardile) located in an inland area of the “National Park of Cilento and Vallo di Diano”, in 
Southern Italy, included in the “Genetic Park of Cilento and Vallo di Diano Project”. Campora and Gioi were set-
tled at the beginning of the 11th century by Greek and Byzantine monks, while Cardile was founded much later, in 
the mid-18th century, by a group of individuals coming from Gioi. Afterwards these populations suffered severe 
bottlenecks due to famine and the epidemic of bubonic plague in the 17th century. Then, they were affected by 
different strong waves of emigration that drastically reduced the population size and experienced a high level of 
reproductive isolation until mid-20th century. As a consequence of the high percentage of endogamous marriages 
among their inhabitants, in each isolate the majority of the current population are connected in a unique huge 
genealogy, and descend from a few number of founding lineages. Also, the presence of inbreeding and a higher 
level of linkage disequilibrium characterize the Cilento isolates when compared to outbred populations12,13. Data 
of the Cilento isolates have contributed to many Genome-wide association studies (GWAS) for several complex 
traits of clinical interest14–20.
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In this work we used the data coming from the WES study performed on the Cilento isolates to describe 
their genetic architecture, annotating the identified variants, cataloguing them according to their frequency and 
functional effects, and comparing their frequencies with those from a general Italian population. Because of the 
initial population bottleneck followed by genetic drift during the first generations, it is expected that in these iso-
lates the frequencies of some genetic variants may have changed compared to those of the founding pool. Some 
variants probably disappeared, thus limiting heterogeneity, while others may have become more frequent, which 
could facilitate their identification. Overall, changes in allele frequency are larger for rare variants than common 
ones. Thus, allele frequencies in isolated populations and large populations are expected to differ the most at rare 
variants. Therefore, rare variants with increased allele frequencies in isolated populations could be more easily 
identified in genetic studies of traits with a Mendelian or complex inheritance. Thus, we focused our attention on 
variants which have an increased allele frequency in the Cilento isolates compared to a general Italian population. 
Among those, we searched for variants of particular interest, such as those having a functional impact on rare 
diseases. Furthermore, we performed different population genetics analyses to better characterize these popu-
lations as genetic isolates. Finally, we tested the utility of using exome data as a local reference panel to improve 
the accuracy of imputation and potentially increase the power of further genetic studies on human traits in these 
populations.
Results
Description of Cilento exome sequencing. The analysis of the whole-exome data on the Cilento popula-
tions revealed high-performance sequencing, with an aligned read mean depth on target regions of 75X.
We found 347,684 variants, 43.8% of which are rare (Minor Allele Frequency, MAF ≤ 1%) and 23.6% have 
MAF between 1% and 5%, giving a total of 67.4% having low frequency (MAF ≤ 5%). 20.7% of all variants iden-
tified in Cilento are singletons (Minor Allele Count, MAC = 1). We grouped sequence variants into four func-
tional impact categories, in order of decreasing severity: 1) HIGH (Loss of Function), including stop-gain or -loss 
variants, frameshift variants, splice donor or acceptor variants and initiator codon variants; 2) MODERATE, 
including missense variants and in-frame insertions and deletions; 3) LOW, including synonymous variants, stop 
retained variants, incomplete terminal codon variants and splice-region variants; and 4) MODIFIER, including 
intronic and intergenic variants, 5′ and 3′ UTR variants, regulatory region and transcription factor binding site 
(TFBS) variants, miRNA variants and non-coding exon variants. We identified 3,562 HIGH impact variants, 
representing approximately 1% of all the variants. On average, each individual carries 319 (range 279–365) HIGH 
impact variants, of which 50 (range 31–68) are in a homozygous state. Rare variants are the most represented in 
the HIGH impact category (58.6%), while frequent variants (MAF > 1%) are more prevalent in both the LOW 
and MODIFIER categories (58.1% and 58.2% respectively) (Fig. 1 and Supplementary Table 1).
Cilento novel variants. Comparing the Cilento exome data with five largely used reference datasets 
(see Methods), we found that 39,946 variants, corresponding to 11.5% of all the identified variants, are novel, 
while 88.5% were found in at least one reference database and 10.9% were shared with all the five databases 
(Supplementary Table 2). The percentage of novel variants in each frequency class decreases as MAF increases (as 
presented in Fig. 2 and in Supplementary Table 2). In accordance with the capacity of WES in identifying new rare 
variants2,10, 87.3% of Cilento novel variants have a MAF below 1% while the remaining 12.7% is distributed in the 
MAF classes above 1%. However, we also identified 19 novel variants (0.047%) with a MAF > 5%.
According to their impact, 70.2% of the novel variants were included in the MODIFIER class, 9.9% in the 
LOW, 18.1% in the MODERATE, and 1.8% (716 variants) in the HIGH class (Supplementary Table 2). We 
observed a statistical significant enrichment of Cilento novel variants in the HIGH and MODIFIER categories 
and a depletion in the MODERATE and LOW classes compared to variants shared with the other databases 
(Supplementary Table 3 and Fig. 3). Overall, these differences were more significant for those variants belong-
ing to the lower MAF classes. In detail, for all variants with MAF < 2% we observed a significant difference in 
Figure 1. Cilento variants. The percentage of variants found in the Cilento whole-exome sequencing study, 
categorized by functional impact and minor allele frequency.
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proportion in all impact classes, while for variants with MAF 2–5% we observed only a significant enrichment 
and depletion in the MODIFIER and the LOW classes respectively.
Exome variants showing an increase in allele frequency in Cilento. To estimate the genetic drift 
in the Cilento isolates, we compared variant allele frequencies (AF) in Campora, Gioi and Cardile with those 
of the Tuscans (TSI) from 1000 Genomes Phase 3 v5 (1KG_Ph3)1, a general Italian population. We will use the 
term ‘increased allele frequency variants’ to describe variants with an AF that is higher in Cilento isolates than in 
TSI. Looking at the variants shared by each Cilento isolate with the Tuscany population (see Methods), we found 
that 118,795 (58.0%), 130,569 (59.8%), and 107,512 (57.4%) variants showed increased AF in Campora, Gioi, 
and Cardile, respectively, with respect to TSI (Supplementary Table 4). Among these, 93,309 increased allele fre-
quency variants in Campora, 97,439 in Gioi, and 87,309 in Cardile were not monomorphic in TSI, and for these 
polymorphic variants we calculated the fold increase in AF respect to TSI following the same approach used in a 
work on two Greek population isolates21. Although the vast majority of these variants exhibits a fold increase <5, 
for 5% of variants in Campora, 3.7% in Gioi, and 6.8% in Cardile we observed a fold increase >5. In particular, 
30 variants in Campora, 7 in Gioi, and 35 in Cardile showed more than 25-fold increase in AF compared to TSI.
The majority of increased allele frequency variants show, as expected, a MAF > 5% in all the three villages 
(53.9% in Campora, 46.5% in Gioi and 60.7% in Cardile), but a considerable proportion of them (13.1%, 18.4% 
and 14.5% in Campora, Gioi and Cardile respectively), which correspond to singletons or doubletons in TSI, are 
still rare (MAF < 1%) in Cilento villages.
According to their functional impact, 0.8% of variants showing an increase in AF in each of the three pop-
ulations (898 in Campora, 977 in Gioi, and 826 in Cardile) were included in the HIGH category, although the 
Figure 2. Cilento novel variants. Percentage of Cilento novel variants (in pink) and shared variants (in 
blue) according to Minor Allele Frequency category and functional impact. The shared variants are grouped 
according to the number of reference databases in which they were found (indicated by different blue shades).
Figure 3. Functional enrichment of Cilento novel variants. The analysis was performed comparing novel 
variants with those shared with at least one reference database. The size of the circles represents the significance 
level of the two-sided test based on asymptotic normal distribution (Fisher exact test for the following 
categories: HIGH/MAF > 5%, MODERATE/MAF > 5%, and LOW/MAF > 5%). The x-axis indicates the fold 
enrichment, the vertical line indicates no enrichment (the proportions in the NOVEL and the SHARED set are 
equal). NS = not significant.
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majority of increased allele frequency variants were in the MODIFIER class (64.0% in Campora, 63.2% in Gioi, 
and 63.6% in Cardile).
Conversely, 85,879 (42.0% of all variants) variants in Campora, 87,701 (40.2%) in Gioi, and 79,747 (42.6%) in 
Cardile had decreased AF compared with TSI.
Gene-enrichment analysis. To discern whether the genes containing the variants showing AF increases 
in each isolate are located in specific pathways, an over-representation analysis was performed using the 
ConsensusPathDB (CPDB) program22. Because of the small sample size of the Cilento isolates (Cardile in par-
ticular), we only considered variants with a fold increase in frequency >5 respect to TSI or variants monomor-
phic in TSI that have a MAF ≥ 0.0223 in Cilento villages (corresponding to a fold increase of 5 for a singleton in 
TSI). This MAF threshold ensures that variants analysed have at least MAC = 3 in Cardile and MAC = 5 in Gioi 
and Campora.
According to these criteria, 9,126 variants in Campora, 6,882 in Gioi and 11,512 in Cardile (only 354 in com-
mon between the three sets), were used for the analysis. These variants mapped to 8,442, 6,710, and 9,979 genes 
respectively (of which 2,087 are in common). Out of these genes, 4,087 in Campora, 3,292 in Gioi, and 4,766 in 
Cardile were found in at least one pathway.
The over-representation analysis identified 23 significantly enriched pathways in Campora, 69 in Gioi, and 73 
in Cardile (Supplementary Table 5). We consider pathways to be significant if they have a q-value (multiple-testing 
adjusted p-value) < 0.05. Of these, 13 pathways were found enriched in all the three analyses, suggesting that, 
despite the very low number of increased allele frequency variants in common between the three villages, many 
are located in genes belonging to the same pathways. Furthermore, additional pathways were found in common 
between two villages: 13 were found both in Gioi and Cardile, 3 in Campora and Cardile and 1 in Campora and 
Gioi. (Table 1). Interestingly, the majority the pathways significantly enriched in common among the three vil-
lages (8 out of 13) are related to the extracellular matrix (ECM) formation and organization - in particular to the 
collagen component - and to its interaction with cell receptors. The remaining enriched pathways are related to 
Vesicle-mediated transport and Transmembrane transport, Protein digestion and absorption, Axon guidance, 
and Stimuli-sensing channels.
As sensitivity analysis we restricted the CPDB over-representation analysis to those variants that showed a 
statistically significant increase (p < 0.05) in AF compared to TSI. Although, in this case, about two-thirds of 
increased allele frequency variants were retained, the identified pathways remain significant at least in one of the 
three villages: among the 13 over-represented pathways, all of them showed a p-value < 0.05 in the three villages, 
and 10 pathways in Gioi and 11 in Cardile showed also a q-value < 0.05. Results of this analysis are reported in 
the Supplementary Table 6.
Rare genetic disease-causing variants. Taking into account the same variants used for the analysis 
described in the previous section, and following a search for them in the ClinVar archive of NCBI (https://www.
Pathway name
Pathway 
size
Campora Gioi Cardile Genes 
contained 
in 
common
Increased 
variants 
in 
common
Genes 
contained p-value q-value
Genes 
contained p-value q-value
Genes 
contained p-value q-value
Axon guidance 357 154 (43.3%) 2.53E-06 1.36E-03 126 (35.4%) 1.97E-05 5.97E-03 171 (48.0%) 1.09E-05 2.37E-03 53 18
Beta1 integrin cell surface 
interactions 66 36 (54.5%) 1.02E-04 2.14E-02 32 (48.5%) 4.98E-05 8.98E-03 40 (60.6%) 8.20E-05 1.01E-02 13 3
Collagen biosynthesis and 
modifying enzymes 67 42 (62.7%) 1.78E-07 1.39E-04 31 (46.3%) 1.94E-04 1.75E-02 41 (61.2%) 4.88E-05 7.64E-03 20 5
Collagen chain trimerization 44 33 (75.0%) 4.57E-09 1.73E-05 27 (61.4%) 5.55E-07 5.01E-04 33 (75.0%) 3.20E-07 1.25E-04 20 5
Collagen formation 91 53 (58.2%) 1.56E-07 1.39E-04 40 (44.0%) 1.02E-04 1.22E-02 59 (64.8%) 6.27E-08 3.06E-05 26 5
ECM-receptor interaction - 
Homo sapiens 82 44 (53.7%) 3.10E-05 8.36E-03 43 (52.4%) 1.70E-07 2.05E-04 54 (65.9%) 1.04E-07 4.50E-05 20 5
Extracellular matrix 
organization 293 136 (46.4%) 8.15E-08 1.39E-04 118 (40.3%) 1.81E-08 6.55E-05 165 (56.3%) 9.41E-12 3.68E-08 62 9
Focal adhesion - Homo 
sapiens 199 91 (45.7%) 2.27E-05 6.58E-03 78 (39.2%) 1.48E-05 5.92E-03 105 (52.8%) 3.78E-06 9.86E-04 33 9
Integrin 124 62 (50.0%) 1.67E-05 5.36E-03 59 (47.6%) 9.41E-08 1.70E-04 77 (62.1%) 1.13E-08 1.11E-05 35 7
Protein digestion and 
absorption - Homo sapiens 90 48 (53.3%) 1.70E-05 5.36E-03 41 (45.6%) 3.05E-05 6.94E-03 50 (55.6%) 2.54E-04 2.24E-02 24 6
Stimuli-sensing channels 102 56 (54.9%) 1.03E-06 6.49E-04 41 (40.2%) 8.21E-04 4.36E-02 60 (58.8%) 5.92E-06 1.45E-03 24 6
Transport of small molecules 666 265 (39.9%) 3.17E-06 1.50E-03 206 (31.0%) 6.83E-04 3.74E-02 324 (48.8%) 1.38E-10 2.69E-07 86 19
Vesicle-mediated transport 620 237 (38.2%) 2.73E-04 4.29E-02 205 (33.1%) 1.18E-05 5.92E-03 295 (47.6%) 2.38E-08 1.55E-05 74 22
Table 1. List of the 13 over-represented pathways in common between the ConsensusPathDB analyses 
performed on the three villages. p-values are calculated according to the hypergeometric test based on the 
number of genes present in both the pathway-based set and input list of genes. q-values represent the p-values 
corrected for multiple testing using the false discovery rate method. The last two columns in the table represent 
the genes used as input for the analyses and the increased allele frequency variants located in those genes, that 
are in common between the three isolates.
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ncbi.nlm.nih.gov/clinvar)23, we found 20 variants increased in AF described as pathogenic for rare genetic dis-
eases in at least one village: 9 variants were identified in Campora, 6 in Gioi, and 12 in Cardile. Also, 10 out of 
the 20 variants were monomorphic in TSI but they showed a MAF ≥ 0.0223 in at least one isolate. The list of 
the identified variants, together with the rare genetic pathologies for which they are responsible is reported in 
Table 2. For each variant, a description of its characteristics as well as those of the related disease is also reported 
in Supplementary Data. Although the overall reported diseases affect a large number of organs/systems, different 
conditions affecting the metabolism, the neurological system, and the eye emerge.
To confirm the increase in allele frequency of the identified variants, we directly genotyped two of them 
(rs72653706 and rs201680145). In particular, the variant rs72653706, selected as a representative of increased 
frequency in all three villages, was directly genotyped in all available samples in Cilento and showed the following 
allele frequencies: Campora AF = 0.027 (40 carriers on 750 genotyped individuals), Gioi AF = 0.008 (12 carriers 
Disease
Orphanet 
Number Orphanet classification Gene Variant
Allele Frequency Fold increase
Campora Gioi Cardile TSI Campora Gioi Cardile
2-methylbutyryl-CoA 
dehydrogenase deficiency 79157
inborn error of metabolism; 
neurological disease ACADSB rs58639322 0.070 0.032 / 0.005 15.0 6.8 /
Autosomal recessive isolated 
neurosensory deafness type 
DFNB
90636 otorhinolaryngologic disease MYO15A rs121908970 / 0.043 0.009 / / / /
Behcet’s syndrome 117
neurological disease; skin 
disease; renal disease; 
eye disease; systemic and 
rheumatological disease; 
circulatory system disease
ADA2 rs146597836 0.027 / 0.060 0.005 5.8 / 12.9
Butyrylcholinesterase 132 inborn error of metabolism; neurological disease BCHE rs28933390 0.124 0.005 0.043 0.019 6.6 0.3 2.3
Carnitine palmitoyltransferase II 
deficiency 157
inborn error of metabolism; 
neurological disease CPT2 rs74315294 0.005 / 0.052 0.005 1.2 / 11.1
Cerebral autosomal 
dominant arteriopathy 
with subcortical infarcts 
and leukoencephalopathy 
(CADASIL)
136 neurological disease; eye disease NOTCH3 rs201680145 / / 0.129 / / / /
Corneal dystrophy Fuchs 
endothelial 98974 eye diseases ZEB1 rs118020901 0.038 / / / / / /
Cowden syndrome 201
gastroenterological disease; 
skin disease; neoplastic disease; 
developmental anomalies 
during embryogenesis
SEC. 23B rs36023150 / 0.048 0.009 0.009 / 5.1 0.9
delta- beta Thalassemia 231237 hematological disease HBD rs35152987 0.027 / 0.009 / / / /
Emery-Dreifuss muscular 
dystrophy 261
cardiac disease; neurological 
disease SYNE1 rs119103248 0.011 / 0.026 0.005 2.3 / 5.5
Hereditary chronic pancreatitis 676 gastroenterological disease; endocrine disease CFTR rs1800111 0.048 0.011 0.052 / / / /
Keratoconus 156071 eye disease ZNF469 rs281865162 / 0.085 0.009 0.005 / 18.2 1.8
Leber congenital amaurosis 4 65 eye disease; ciliopathy AIPL1 rs62637014 0.011 / 0.043 / / / /
Leber congenital amaurosis 6 65 eye disease; ciliopathy RPGRIP1 rs17103671 / 0.011 0.026 0.005 / 2.3 5.5
Microphthalmia syndromic 9 2470
eye disease; respiratory 
disease; surgical thoracic 
and abdominal disease; 
developmental anomalies 
during embryogenesis
STRA6 rs118203962 0.032 / / 0.005 6.9 / /
Odontoonychodermal dysplasia 99798 odontological disease WNT10A rs121908120 0.011 0.037 0.043 0.005 2.3 8.0 9.2
Primary ciliary dyskinesia 244 respiratory disease; infertility disorder; ciliopathy RSPH1 rs138320978 0.005 0.027 0.017 / / / /
Pseudoxanthoma elasticum 758
eye disease; skin disease; 
renal disease; neurological 
disease; cardiac disease; 
circulatory system disease; 
developmental anomalies 
during embryogenesis
ABCC6 rs72653706 0.054 0.016 0.026 / / / /
Rare hereditary thrombophilia 217454
hematological disease; systemic 
and rheumatological disease; 
bone disease
F5 rs6025 0.054 / 0.052 0.005 11.5 / 11.1
Tyrosinemia type I 882
inborn errors of metabolism; 
neurological disease; hepatic 
disease; renal disease; neoplastic 
disease
FAH rs11555096 0.016 0.005 0.060 0.005 3.5 1.1 12.9
Table 2. Rare disease causing variants, reported as Pathogenic in ClinVar database, increased in allele 
frequency in at least one Cilento isolate. Fold increases ≥5 and allele frequencies ≥0.0223 are reported in bold.
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on 720), and Cardile AF = 0.046 (50 carriers on 544). No individual was homozygous for the deleterious allele 
in the Cilento villages. One individual, not included in the WES study, was found to be heterozygous for the 
rs72653706 variant and was affected by Pseudoxanthoma Elasticum, as reported in the clinical data collected. The 
hypothesis that this individual is a compound heterozygous should be further verified. The variantrs201680145, 
responsible for CADASIL disease, and chosen due to its presence in the Cardile population, was directly gen-
otyped on the overall Cardile sample, confirming the presence of the disease allele in this population with an 
AF = 0.073 (76 heterozygous and 3 homozygous individuals on 564 genotyped individuals).
Population Genetics analyses. To characterize the genetic differentiation of the Cilento isolates, a 
Principal Component Analysis (PCA) was performed including data of each village and TSI population. The anal-
ysis, both using common (MAF > 5%) and rare and low-frequency (MAF ≤ 5%) variants revealed three defined 
clusters corresponding to the three isolates, with the first principal component discriminating Campora and 
Cardile from Gioi and the second principal component separating Campora and Cardile from TSI. We observed 
that Gioi partially overlaps with TSI, in particular when considering rare and low frequency variants (Fig. 4a,b). 
Effective population size (Ne) history based on LD estimations reveals that the three isolates have substantially 
smaller Ne compared to the Italian general population (TSI). The analysis showed that 30,000 years ago there 
was a comparable size among the three isolates (about 3,500 for isolates vs 4,500 for TSI). After, while the Ne of 
Campora and Cardile approximately remains unchanged over time, the Ne of Gioi tends to increase but always 
remaining smaller than TSI. At 5,000 years ago; the isolate population sizes diverge considerably with Ne~3,000 
in Campora and Cardile, Ne~5,000 in Gioi vs Ne~10,000 in TSI (Supplementary Fig. 1).
To detect autozygosity, we searched for Runs of Homozygosity (ROH). These are contiguous regions of the 
genome where an individual is homozygous across all sites. This analysis revealed that Campora, Cardile and 
Gioi show a significantly higher number of homozygous segments (5.58, 5.57 and 3.67 on average, respectively), 
Figure 4. PCA analysis. Principal components analysis of Campora, Gioi and Cardile, combined with the 
Tuscan (TSI) population from the 1000 Genomes Phase 3 v5 reference panel. The analysis was performed using 
(a) common (MAF > 5%) and (b) rare and low frequency (MAF ≤ 5%) variants in common between the Cilento 
isolates and TSI. We compare the first and second principal components (PC1 and PC2, respectively).
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compared to TSI (1.48, Campora-TSI p = 5.42E-17, Cardile-TSI p = 1.76E-11, Gioi-TSI p = 1.16E-5). These seg-
ments have a greater mean length in Cilento isolates compared to TSI (Campora = 3.87 Mb, Cardile = 4.34 Mb, 
Gioi = 2.82 Mb, TSI = 1.42 Mb; Campora-TSI p = 7.49E-20, Cardile-TSI p = 2.23E-11, Gioi-TSI p = 5.11E-8,) 
(Fig. 5a). Also, the total length of ROH is significantly higher in Campora (23.84 Mb), Cardile (25.38 Mb) and 
Gioi (14.48 Mb) compared to TSI (3.54 Mb, Campora-TSI p = 1.19E-15, Cardile-TSI p = 1.67E-10, Gioi-TSI 
p = 2.15E-5) (Fig. 5b).
The analysis also revealed that, while in TSI the majority of ROH show a length between 1 and 2 Mb (~60%), 
in Cilento populations these short segments represent less than 30% of the total, while a higher prevalence of long 
segments (>2 Mb) can be observed in these populations compared to TSI. This is especially evident for segments 
with a length >10 Mb, which occur with a frequency of 1.27% in TSI, while they reach a frequency of 7.51% in 
Campora, 8.98% in Cardile and 6.38% in Gioi (Supplementary Fig. 2). These results are in agreement with isola-
tion and the presence of consanguineous unions in the history of these populations.
Improvement of Imputation. Two imputation strategies were compared on the Cilento dataset on chro-
mosome 10: firstly using the latest release of the 1KG_Ph3 and secondly using a combination of the 1KG_Ph3 
and a local reference panel of haplotypes created by phasing the Cilento WES data (we denote these two impu-
tation strategies as ‘1KG_Ph3’ and ‘1KG_Ph3 + WES’). Over the entirety of chromosome 10, 3,921,562 and 
3,923,571 variants were imputed by the strategies 1KG_Ph3 and 1KG_Ph3 + WES respectively. Indeed, including 
this WES local reference panel will allow the imputation of the previously discussed novel variants of Cilento. 
We compared imputation quality scores for variants that were neither imputed as monomorphic or present on 
either of the two genotyping arrays used in Cilento; our comparison involved 2,321,569 variants including 7,545 
exonic variants present in the WES panel. In agreement with a recent study on simulated data in Campora24 and 
other studies examining population specific imputation panels25–28, our analysis revealed the addition of the WES 
panel improved the quality of imputation, particularly for low frequency exonic variants. Indeed, the inclusion 
of the WES panel led to an average increase in the ‘info’ score by 2.1% (0.96 to 0.98) across exonic variants with a 
MAF > 0.05 and by 15.9% (0.77 to 0.89) over exonic variants with MAF ≤ 0.05 (Fig. 6). From the set of variants 
used for the comparison of imputation strategies, 1KG_Ph3 + WES imputed variants had higher ‘info’ scores: the 
number of poorly imputed variants (‘info’ <0.4) was 1,259,194 under 1KG_Ph3 + WES compared to 1,300,113 
under 1KG_Ph3 and the number of confidently imputed variants (‘info’ >0.7) was 872,425 under 1KG_Ph3 + 
WES compared to 756,520 under 1KG_Ph3 (+15.3% of confidently imputed variants).
Figure 5. Runs Of Homozygosity (ROH) analysis. (a) Mean and (b) total length (Mb) of ROH in Campora, 
Gioi, Cardile and TSI populations. Only ROH with length >1 Mb are shown.
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Discussion
Next-generation sequencing approaches have produced a more comprehensive survey of the genetic diversity in 
human population improving knowledge of population history and disease mapping studies. These studies are 
particularly interesting in founder populations which constitute a special resource due to the effects of bottlenecks 
and drift on their genetic variation. In fact, several examples of complex trait associations in isolates involve var-
iants that are rare or at low frequency in the general population yet are shown to occur with greater frequency 
in the studied population isolates29–32. This work provides a deep description of the exonic architecture of the 
isolated populations of Cilento, and represents the largest exome variant analysis in a population-based study in 
Southern Italy. The study identifies several variants with an increased allele frequency that could be prioritized 
in genetic association studies and for which fewer individuals would be required to achieve sufficient power to 
detect association. In line with a founder effect, some mutations, responsible for rare genetic conditions, are at 
high frequency in Cilento isolates.
In this study we have identified 347,684 variants, the vast majority of which (over two thirds) are rare or at low 
frequency. This is in accordance with other previous studies on whole-exome sequencing analysis2,4. According 
to the effect of variants, each person in our study carries, on average, 319 HIGH impact variations; a lower burden 
of deleterious variations per person was reported in a similar study on the isolated population of VIS in Croatia2. 
However, in that case a slightly different classification of loss of function variants was used including only the 
stop-gained (nonsense) or splice site-disrupting (splice donor or acceptor) variants.
By comparing the Cilento sequences with data from five public databases we have identified many novel, 
Cilento specific variants, representing more than 11% of the total set of variations found in Cilento. This was 
similar to the percentage observed in an exome-sequencing study on an isolated population from the Dalmatian 
island of Vis (9%; where five databases were explored)2 and lower than the percentage reported in a whole-exome 
sequencing study of a French-Canadian founder population (20%; but here only the 1000 genome database was 
explored)4. As already found in other studies on isolated populations2,10, novel variants were enriched in rarity 
and functional relevance, which is expected as these variants have not fully undergone purifying selection due to 
the relatively recent foundation of these isolates.
The comparison of allele frequencies of the Cilento isolate variants with those from the Tuscan population, 
a general Italian population, highlighted the existence of variations that have drifted positively in frequency in 
Cilento. Interestingly, a pattern of common enriched pathways, mainly related to extracellular matrix formation 
and organization, was found in all the three villages. Genes related to collagen proteins and the extracellular 
matrix, and genes associated with the anatomy and physiology of cilium were reported to be potentially targets 
of positive selection in a study on mammal adaptation to environment33. Also, it has been reported in other 
two human populations that extracellular matrix genes show strong signs of balancing selection34. A work by 
Fumagalli et al. showed that genes coding for extracellular matrix component are implicated in an anti-viral 
response and can be thought of as targets of a virus-driven selective pressure35.
Genetic variations with increased AF in Cilento also included several rare disease causing variants responsi-
ble especially for pathologies compatible with life and reproduction for which high frequencies of carriers were 
observed. As these disease-variants were responsible for a number of diseases, it is unlikely that all these different 
conditions have been the subject of a carrier selective advantage. Therefore, although that hypothesis cannot be 
excluded, the results suggest that a stochastic effect of drift is most likely to represent the main force generating 
high carrier frequencies in Cilento. Recent studies on exome data have been focused on a survey of disease-allele 
Figure 6. Improvement of imputation. Comparison of IMPUTE2 imputation quality score ‘info’ between 
two imputation strategies: firstly using the 1000 Genomes Phase3 v5 reference panel (‘1KG_Ph3’ – red) and 
secondly using a combination of the 1000 Genomes Phase3 v5 reference panel and a local reference panel of 
phased exome data from Cilento (‘1KG_Ph3 + WES’ – blue). Imputation was performed on the entirety of 
chromosome 10. Mean ‘info’ scores for 50 MAF bins are presented and results are split between all imputed 
variants (left) and only imputed exonic variants (right).
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carrier frequency at population level in both isolate communities and general populations revealing strong pop-
ulation specificity and variability of disease alleles36,37. In this context, our study provides a contribution to the 
frequency of rare disease causing variants in the Cilento region. Studies as such applied to larger exome/whole 
sequencing data from general population in Southern Italy, might contribute to create comprehensive panels of 
genetic screening of clinical interest.
We have added confirmation of the genetic isolation of the Cilento populations. Indeed, autozygosity, 
detected through ROH analysis on WES variants, revealed longer homozygous segments, especially in Campora 
and Cardile, compared to the general population, in accordance with similar findings obtained in two stud-
ies on Greek and other European isolated populations, in which ROH were called from SNP array data and 
whole-genome sequencing data, respectively11,21. The exome analysis confirmed previous findings from SNP chip 
data38 and places Cilento among the other European and Italian isolates for which WGS data are available.11. 
Furthermore, the results obtained from the PCA and the Effective Population Size analyses, confirmed a genetic 
differentiation of the Cilento isolates from the general Italian population. This differentiation was greater for 
Campora and Cardile compared to Gioi, as previously reported12,13. Effective Population Size analysis shows that 
isolates from Southern Italy differentiated from Italian general population similarly to isolates from Northern 
Italy11.
Finally, in accordance with previous studies demonstrating that the addition of a local reference panel in the 
genome-wide imputation procedure substantially improves the imputation quality, especially for rare and low fre-
quency variants24–28, we reported a greater accuracy in the imputation especially for rare variants in Cilento when 
using a local reference panel. This will open up the opportunity for future GWAS for complex traits in Cilento 
including well imputed low frequency variants and indeed novel Cilento variants. This may potentially provide, 
in turn, a more complete description of the genetic architecture for such traits.
Methods
participant recruitment and sample collection. We conducted exome-wide sequencing of 247 individ-
uals from the isolated villages (Campora (N = 93), Gioi (N = 94) and Cardile (N = 60)) in the Cilento area, South 
Italy. The sample for this study was based on the initial cohort of 2,137 participants, which were recruited in the 
Genetic Park of Cilento and Vallo di Diano Project between 2003 and 2008. Sequenced samples were selected 
on the basis of three criteria: i) they (and both their parents) were born in one of the three Cilento villages; 
ii) they had been already genotyped with Illumina 370 K or OmniExpress arrays; iii) they maximize the whole 
sample haplotype representation, as they were selected using the procedure proposed by Uricchio39. We adapted 
Uricchio’s procedure from pedigree to exome data as follow: for the 1,617 individuals genotyped with one of the 
two Illumina arrays, the Identical by Descent (IBD) segments were reconstructed with GERMLINE using the 
192,092 SNPs in common between the two chips. Then the segments located on exome regions were selected 
to calculate the exome kinship using the estimated Jacquard identity coefficients40. Finally, the person with the 
highest average kinship to the other individuals in the study was chosen and subsequently, in an iterative manner, 
the individuals who had the highest average kinship to the remaining unselected individuals, but who had kinship 
not exceeding 0.1 with any other individual already selected for sequencing, were selected.
Mean genomic kinship of the 247 individual sample was 0.007, as estimated by GenABEL library41.
The study design was approved by the ethics committee of Azienda Sanitaria Locale Napoli 1 and the ethics 
committee “Carlo Romano” University of Naples “Federico II”. The study was conducted according to the criteria 
set by the declaration of Helsinki and each subject signed an informed consent form before participating in the 
study.
exome capture and sequencing. Sequencing was performed at the Wellcome Trust Sanger Institute, 
Hinxton, Cambridge, UK. Genomic DNA (approximately 1 μg) was fragmented to an average size of 150 bp and 
subjected to DNA library creation using established Illumina paired-end protocols. Adapter-ligated libraries were 
amplified and indexed via Polymerase Chain Reaction (PCR). A portion of each library was used to create an 
equimolar pool comprising eight indexed libraries. Each pool was hybridised to SureSelect RNA baits (Human 
All Exon V5; Agilent Technologies) and sequence targets were captured and amplified in accordance with the 
manufacturer’s recommendations. Enriched libraries were subjected to 75 base paired-end sequencing (HiSeq 
2000; Illumina) following the manufacturer’s instructions.
Variant calling, filtering and annotation. Sequence reads were aligned with the Burrows-Wheeler 
Aligner (BWA, v0.5.10) algorithm on to the GRCh37 human assembly. The paired-read alignments were sorted 
and stored in BAM format using samtools (v0.1.18). Duplicates were marked with Picard (v1.72), and local 
re-alignment and Base Quality Score Recalibration were carried out using Genome Analysis Toolkit (GATK, 
v1.5–9, https://software.broadinstitute.org/gatk/)42.
After data pre-processing, a multi-sample variant-calling was performed using Samtools mpileup (v0.1.19). 
GATK Unified Genotyper (v1.5-32-g2761da9) was used to recall the sites discovered by samtools and to per-
form the Variant Quality Score Recalibration (VQSR). Single Nucleotide Variants (SNVs) and indels were filtered 
by minimum VQSLOD score corresponding to the truth sensitivity threshold of 99.5% and 95% respectively. 
Genotypes with a depth (DP) < 4 and/or a genotype quality (GQ) < 60 for that particular call, were set as null 
genotypes.
Called variants were annotated with dbSNP137 rsIDs and 1000 Genomes super population allele frequencies 
that were extracted from the final 1000 Genomes Phase 1 integrated (v3) callset.
Functional annotations were called with the Ensembl Variant Effect Predictor (http://www.ensembl.org/info/
docs/tools/vep/index.html)43 against Ensembl 75, which provided genes and transcripts affected by the vari-
ants, location, coding consequence predictions and SIFT, PolyPhen and Condel annotations as well as GERP 
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conservation scores. The most deleterious effect, according to severity estimated by Ensembl (https://www.
ensembl.org/info/genome/variation/prediction/predicted_data.html), was assigned to each variant.
Performance of whole-exome sequencing. Performance of whole-exome sequencing was evaluated 
using GATK42. We collected high-coverage exome sequencing data for 247 samples with a mean of 83.3 million 
reads per subject. When PCR duplicates were removed, 69.8 million reads (83.9%) per individual were retained.
The mean value of aligned-read depth on the target regions (~50 Mb) was ~75x (range 57–103x) with more 
than 85% of target regions covered by at least 30x, and 66% covered by at least 50x. Considering also the calling 
regions outside the targets (for a total of ~90 Mb), the mean value of depth per individual was 50 (range 39–72), 
with 75% of positions covered by at least at 30x.
Per-sample and per-variant Quality control. The sample-level Quality Control (QC) criteria were: (a) 
genotype concordance for the overlapping set of individuals/SNPs between the Cilento genome-wide data (geno-
typed using Illumina 370 K or OmniExpress arrays) and whole-exome sequences. Two individuals (from Cardile 
population) with more than 50 discordant sites were excluded. A very high genotype concordance rate (mean 
99.8%, SD 0.05%) was observed for the remaining individuals; (b) a sample call rate exclusion threshold of 90% was 
applied with no sample exclusion; (c) the heterozygosity exclusion threshold of ±3 standard deviations (SD) from 
the mean was used again with no sample exclusion; (d) outliers were searched for using multidimensional scaling 
analysis (MDS), plots were visually inspected and no subjects were excluded. Per-sample QC steps were performed 
using PLINK 1.944. Samples failing sample-level QC were removed prior to performing variant-level QC.
The variant-level QC step was carried out under the following criteria: (a) only variants that were autosomal, 
biallelic, and polymorphic in the Cilento sample (MAC ≥ 1) were included; (b) variant call rate threshold of 95% 
was applied; (c) deviation from Hardy-Weinberg equilibrium (HWE) was calculated and variants falling below 
the threshold for HWE, exact p-value < 1 × 10−4, were excluded. All variants failing QC steps were removed. All 
subsequent analyses were performed using clean post-QCed datasets. Per-variant QC steps were performed using 
VCFtools (v0.1.12b).
The post-QC Cilento exome-sequence dataset contained 245 (93 from Campora, 94 from Gioi and 58 from 
Cardile) individuals (45.7% males) and 347,684 variants.
Ti/Tv ratio. To assess the probability of false positives we evaluated aggregate transition-transversion (Ti/Tv) 
ratio for all variants that passed QC. Average Ti/Tv ratio for targeted regions over all subjects and all locations was 
2.57, in accordance with the value expected in such studies.
Cilento variant analysis. As the sequenced individuals were selected to be not closely related to each other, 
their relationship should not influence the allele frequency estimation. For this reason, the MAF of the variants 
identified in the Cilento sample was calculated by naive counting. According to their MAF, we classified the 
347,684 variants in 6 categories: singletons (MAC = 1), doubletons (MAC = 2), ≤1%, 1–2%, 2–5%, >5%. The 
accuracy of singletons was verified by looking at allele transmission in a subset of 6 out of the 245 individuals who 
were part of parent-child couples for which additional whole-genome sequences were also available. On average, 
we observed a transmission rate of 50.5% for these variants, as expected. This result indicates that the identified 
singletons are unlikely to be false positive variants.
Also, sequence variants were classified into four functional impact categories, in order of decreasing sever-
ity: HIGH (Loss of Function), MODERATE, LOW, and MODIFIER, following functional annotation groups 
as reported by Ensembl (https://www.ensembl.org/info/genome/variation/prediction/predicted_data.html). In 
order to identify novel variants not reported in the reference datasets, we compared the Cilento exome data 
with five databases: HapMap3 release 2 (http://www.hapmap.org), 1KG_Ph3 (http://www.internationalgenome.
org/), Haplotype Reference Consortium (HRC) release 1.1 (http://www.haplotype-reference-consortium.org/), 
dbSNP142 (https://www.ncbi.nlm.nih.gov/projects/SNP/), and ExAC release 0.3.1 (http://exac.broadinstitute.
org/). To check if a Cilento variant was shared with a reference database we matched chromosome, position and 
both the alleles (including multiallelic variants in reference database).
Functional enrichment of novel variants. To test for functional enrichment of Cilento novel variants, we 
divided all variants in two groups: those found in at least one of the five reference database (SHARED) and those 
private to Cilento (NOVEL). Variants were then grouped by MAF and impact categories, as described above. Two 
sided tests based on asymptotic normal distributions were used to compare the proportion between the SHARED 
and NOVEL datasets for each MAF and Impact category. A Fisher exact test was used instead for the categories 
containing variant counts <5. Fold enrichment was calculated with the following equation:
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where EM i, is the fold enrichment of impact i in M MAF category; VN
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M i,  are the number of variants in 
M  MAF category with impact i in the NOVEL and the SHARED dataset respectively; tN
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M are the total 
number of variants in the M  MAF category in the NOVEL and the SHARED dataset respectively. Bonferroni 
corrections of the p-values were applied to account for multiple testing.
Allele frequency comparison. To examine the genetic drift in the Cilento isolates, we compared the allele 
frequencies of all variants in Campora, Gioi, and Cardile (N = 93, 94, and 58 samples, respectively) against their 
respective frequencies in the TSI sample (N = 112). To do this, in each population, variants shared with TSI were 
1 1Scientific RepoRts |          (2019) 9:4059  | https://doi.org/10.1038/s41598-019-41022-6
www.nature.com/scientificreportswww.nature.com/scientificreports/
selected to be: autosomal, biallelic (removing variants with discordant alleles), with HWE p ≥ 10−4 and callrate 
>0.95. Applying these filters 204,674, 218,270, and 187,259 variants were analysed in Campora, Gioi, and Cardile, 
respectively. For each variant (except for those monomorphic in TSI) we calculated the fold increase allele fre-
quency (AF) as AFisolate/AFTSI, considering as reference allele the minor allele in TSI.
Gene-enrichment analysis. An enrichment analysis for genes mapped by variants increased in allele 
frequency in each Cilento population versus the TSI population was performed using the Over-representation 
analysis option in ConsensusPathDB program (http://cpdb.molgen.mpg.de/). In particular, in each isolate we 
selected the genes mapped by all the variants that: a) showed an AF fold-increase ≥5 compared to TSI or b) were 
monomorphic in TSI (for which it was not possible to calculate the fold-increase value) and have a MAF ≥ 0.0223 
in the isolate (this value corresponds to a fold-increase of 5 for MAC = 1 in TSI).
Pathways were considered as significantly enriched if they had q-value < 0.05 in CPDB analysis.
A sensitivity analysis for the over-represented pathways found in this analysis was also performed. In this 
case, among the variants previously considered we selected those showing a statistically significant enrichment in 
AF compared to TSI. The statistical significance of increases was calculated on the allele counts in TSI and each 
Cilento village, using a Fisher exact test. Only variants with a p-value < 0.05 were considered to select the genes 
for the sensitivity analysis.
Rare disease-causing variants. Variants increased in allele frequency in the isolates were searched for in 
ClinVar (Human Variation of Clinical Significance) database (ftp://ftp.ncbi.nih.gov/pub/clinvar/vcf_GRCh37/
clinvar_20170530.vcf.gz) to identify those responsible for rare genetic diseases. Chromosome, position and alleles 
were used to match the variants increased in allele frequency in Cilento with those included in the ClinVar. 
Only those variants indicated as Pathogenic in ClinVar and reported in the OrphaNet database (www.orpha.net) 
because responsible for rare conditions, were selected. Direct genotyping of the rs72653706 variant on the overall 
population sample (Campora N = 750, Gioi N = 720, Cardile N = 544) and of the rs201680145 variant on the 
Cardile population sample (N = 564) was performed by TaqMan assay (Bio-Rad, USA). Genotype concordance 
between WES and genotyping data was verified, and no inconsistencies were found.
Population Genetics Analyses. 166,496 variants in common between Cilento villages and TSI, were 
selected for the analyses.
A Principal Component Analysis (PCA) was performed on Campora, Gioi, Cardile, and TSI with PLINK 1.9 
software44, using the 106,828 common (MAF > 5%) and the 59,668 rare and low-frequency (MAF ≤ 5%) variants 
separately.
LD-based demographic inference for the Cilento and TSI populations was performed in the NeON 
R-package45, reconstructing the long term effective population size (Ne) from 5000 to 30000 years ago.
To detect the ROH, 60,837 among the 106,828 common variants were selected to be independent using the 
LD pruning option of PLINK 1.9: In windows of 50 SNPs, LD is calculated between each SNP pair, if for a pair of 
SNPs, the LD r2 exceeds 0.8 then one SNP is removed. This process is then repeated by sliding the window down 
the chromosome in increments of five SNPs. The ROH were reconstructed in Campora, Gioi, Cardile, and TSI 
applying the parameters optimized for WES analysis. That is, ROH was required to comprise a minimum of 50 
consecutive homozygous SNPs without any heterozygous sites (options in Plink were as follows: –homozyg-snp 
50, –homozyg-window-het 0)46. Only ROH with a length >1 Mb were selected. For each individual included in 
the analysis, the total number of segments, the total length (corresponding to the sum of ROH), and the mean 
length (the total length divided by the total number) of ROH were calculated. T-tests were used to test the statis-
tical significance of the differences in means between populations.
Imputation quality. We sought to verify if the use of the Cilento WES data as a local reference panel (LRP) 
in addition to the 1KG_Ph31 could improve the accuracy of genome-wide imputation. To do this, we performed 
two imputations: the first using only the 1KG_Ph3 as reference panel, the second using a combination of both the 
1KG_Ph3 and a Cilento LRP of WES data (1KG_Ph3 + WES). Variants from both Illumina 370 K and OmniExpress 
arrays and WES on chromosome 10 were filtered for genotyping call rate ≥95% and MAF ≥ 0.01. Mendelian errors 
in the genotyping data were located with PLINK 1.9 and set to missing. Two individuals were excluded from this 
analysis for having array genotyping rates below 70%. Haplotypes were reconstructed in two groups, one for each 
genotyping platform. To create the LRP for Cilento, WES data and SNPs present on both genotyping arrays were 
merged for the 245 exome sequenced individuals with high quality genotypes47. Discordant genotypes were set 
to missing (a mean concordance of 99.6% between WES and array genotypes was observed on chromosome 10). 
SHAPEIT2 was used for phasing both the 370 K and OmniExpress groups, as well as the LRP. We ran SHAPEIT2 
with default settings apart from the following specifications: 15 burn-in iterations, 15 pruning iterations, 35 main 
iterations, and the ‘duohmm’ option48. We also supplied the 1KG_Ph3 as a reference panel for phasing. Imputation 
was performed on the 370 K and OmniExpress groups using IMPUTE249 with default settings, windows of size 
5 Mb, and buffer regions of size 250 Kb. The ‘merge-ref-panels’ option was used to perform imputation with a com-
bination of the 1KG_Ph3 and the phased WES LRP. For each variant imputed in both groups, the IMPUTE2 quality 
score (‘info’) was calculated using QCTOOL (http://www.well.ox.ac.uk/~gav/qctool_v2/) from the imputed dosages 
of all individuals except those in the LRP. The ‘info’ score is an “information measure” that assesses the imputation 
quality of a SNP. The ‘info’ takes values between 0 and 1, where higher values indicating that a SNP has been imputed 
with higher certainty. This serves as a proxy for a measurement of imputation accuracy50. A threshold of 0.4 for the 
info score is generally used to select well-imputed variants to be used in GWAS. We then compared ‘info’ scores from 
different imputation pipelines against MAFs calculated on the European populations in the 1KG_Ph3.
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Data Availability
The datasets generated during and analysed during the current study are available in the European Genome-phe-
nome Archive (EGA) repository, https://www.ebi.ac.uk/ega/datasets/EGAD00001002195.
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